Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $24.25.
Several research firms have recently issued reports on ANL. Oppenheimer began coverage on shares of Adlai Nortye in a report on Thursday, May 28th. They issued an “outperform” rating and a $32.00 price objective for the company. Wall Street Zen raised shares of Adlai Nortye to a “hold” rating in a report on Saturday, March 7th. HC Wainwright upped their price target on shares of Adlai Nortye from $16.00 to $20.00 and gave the company a “buy” rating in a report on Monday, April 20th. JonesTrading began coverage on shares of Adlai Nortye in a report on Thursday, May 14th. They issued a “buy” rating and a $22.00 price target for the company. Finally, Leerink Partners began coverage on shares of Adlai Nortye in a report on Friday, March 20th. They issued an “outperform” rating and a $23.00 price target for the company.
View Our Latest Report on Adlai Nortye
Adlai Nortye Stock Performance
Institutional Investors Weigh In On Adlai Nortye
Institutional investors and hedge funds have recently bought and sold shares of the business. Affinity Asset Advisors LLC acquired a new stake in shares of Adlai Nortye during the first quarter worth $1,140,000. ADAR1 Capital Management LLC acquired a new stake in shares of Adlai Nortye during the first quarter worth $816,000. Renaissance Technologies LLC acquired a new stake in shares of Adlai Nortye during the first quarter worth $457,000. Finally, SmartHarvest Portfolios LLC raised its position in shares of Adlai Nortye by 8.5% during the first quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after purchasing an additional 1,279 shares during the period. 35.21% of the stock is owned by institutional investors and hedge funds.
Adlai Nortye Company Profile
Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
See Also
- Five stocks we like better than Adlai Nortye
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.
